Serial Number | 79377711 |
Word Mark | BIOLINERX |
Filing Date | Tuesday, May 23, 2023 |
Status | 686 - PUBLISHED FOR OPPOSITION |
Status Date | Tuesday, June 11, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, June 11, 2024 |
Goods and Services | Pharmaceutical product development services, namely, pharmaceutical product development through the discovery of compounds that helps for the treatment of a variety of diseases and symptoms; pharmaceutical product development services for a wide variety of diseases and symptoms, namely, neuropathic pain, acute kidney injury, inflammatory bowel disease, adult diabetes, weight loss among cancer patients, bacterial infections, rheumatoid arthritis, celiac disease, psoriasis, solid cancerous tumors, myocardial infarction, schizophrenia and prostate cancer; pharmaceutical product development services of new compounds for use in medicines for oncology patients; pharmaceutical research services; research and development services in the field of biotechnology |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, September 1, 2023 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | BioLineRx Ltd. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | IL |
Party Name | BioLineRx Ltd. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | IL |
Event Date | Event Description |
Thursday, August 31, 2023 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Tuesday, May 7, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, September 1, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, September 5, 2023 | APPLICATION FILING RECEIPT MAILED |
Thursday, February 15, 2024 | ASSIGNED TO EXAMINER |
Tuesday, February 20, 2024 | NON-FINAL ACTION WRITTEN |
Wednesday, February 21, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Tuesday, March 12, 2024 | REFUSAL PROCESSED BY MPU |
Wednesday, March 13, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Tuesday, April 2, 2024 | REFUSAL PROCESSED BY IB |
Tuesday, May 7, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, May 7, 2024 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
Tuesday, May 7, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Tuesday, May 7, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Tuesday, May 7, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Tuesday, May 7, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Tuesday, May 7, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Tuesday, May 7, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Wednesday, May 8, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, May 22, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, June 11, 2024 | PUBLISHED FOR OPPOSITION |
Thursday, July 25, 2024 | TEAS REQUEST FOR TRANSFORMATION RECEIVED |
Tuesday, June 11, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |